2021 Revenues ($USD) : $5,857,894,737
2021 Revenues (foreign currencies) : ¥625,506,000,000
2021 R&D spend : $509,833,302
2021 Number of Employees : 21,512
Fiscal Year End : 3/31/2021
Key People : Yasuo Takeuchi, president and CEO; Nacho Abia, COO; Akihiro Taguchi, chief technology officer; Chikashi Takeda, CFO; Stefan Kaufmann, chief administrative officer.

About the company: Tokyo-based Olympus Group makes precision machines and instruments. Its medical devices primarily serve gastroenterology, general surgery, pulmonology, bronchoscopy, urology, gynecology, otolaryngology, bariatrics, orthopedics and anesthesiology. Founded in 1919, the company developed the world’s first gastrocamera in 1950 and now offers endoscopes, endoscope reprocessors, laparoscopes, video imaging systems, system integration solutions and medical services through its Endoscopy unit. Its Therapeutic portfolio includes surgical energy devices and instruments to help prevent, detect and treat disease, such as devices for endotherapy, urology/gynecology, respiratory heath and ear/nose/throat applications. Scientific Solutions, a third business unit outside of Medical Solutions, makes microsocope systems for the life science industry, as well as videoscopes, nondestructive testing technology and X-ray analyzers.  –JH